One Supplement that ACTUALLY prevents Cancer: 6 Studies - Everything Revealed

*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 *HEALTH AUTONOMY [COURSE]*Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy*JOIN THE COMMUNITY*Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2*EMAIL LIST*1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6*HIRE ME FOR CONSULTING:* Consulting: https://bit.ly/3dmUl2H Created with BiorenderBerberine Clinical Analysis of Colon Cancer: https://www.youtube.com/watch?v=f60S4WpsRt4Fiber on Cancer: https://www.youtube.com/watch?v=mZOCHKgsjCA0:00 - Introduction0:42 - Berberine prevents Cancer1:22 - The Microenvironment3:45 - All about Glucose - or is it?5:21 - Supplement Berberine or…[Study 550] Chen YX, Gao QY, Zou TH, et al. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study. Lancet Gastroenterol Hepatol. 2020;5(3):267-275. doi:10.1016/S2468-1253(19)30409-1Funding/Conflicts: Public Funding: Supported by grants from the National Natural Science Foundation of China (81421001, 81530072, 81830081, 8177100232), plus funding from Shanghai Shenkang Center (SHDC12018121), Shanghai Municipal Key Clinical Specialty, the Innovative research team of high-level local universities in Shanghai, the Top-Notch project of China, and the Shanghai Municipal Education Commission–Gaofeng Clinical Medicine Grant (20152514); Non-Profit Funding: None reported; Industry Funding: None reported; Conflicts of Interest: The authors declared no competing interests. [Study 551] Tan YJ, Zou TH, Yu K, et al. Berberine for preventing colorectal adenoma recurrence and neoplasm occurrence: 6-year follow-up of a randomized clinical trial. Cell Rep Med. 2025;6:102293. doi:10.1016/j.xcrm.2025.102293Funding/Conflicts: Public Funding: Supported by grants from the National Natural Science Foundation of China (82330086, 8220110843, 82250005, 82273140, 82372849), the National Key R&D Program of China (2020YFA0509200), the Shanghai Shenkang Hospital Development Center (SHDC2020CR1034B), the Innovative Research Team of High-level Local University in Shanghai (SHSMU-ZDCX2021030), and number B23 of the 2030 plan from Shanghai Jiao Tong University (WH510272101); Non-Profit Funding: None reported; Industry Funding: None reported; Conflicts of Interest: The authors declare no competing interests. [Study 602] Yu YN, Yu TC, Zhao HJ, Sun TT, Chen HM, Chen HY, et al. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Oncotarget. 2015;6(31):32013-32026. doi:10.18632/oncotarget.5166.Funding/Conflicts: Public Funding: This work was supported by grants from the National Natural Science Foundation (Grant No. 81320108024 and 81421001) and The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. 201268); Non-Profit Funding: None reported; Industry Funding: None reported; Conflicts of Interest: The authors declare no potential conflicts of interest.[Study 605] Yan SH, Hu LM, Hao XH, Liu J, Tan XY, Geng ZR, et al. Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer. iScience. 2022;25:104773. doi:10.1016/j.isci.2022.104773Funding/Conflicts: Public Funding: Supported by the National Natural Science Foundation of China (21976080, 21873045); Non-Profit Funding: None reported; Industry Funding: None reported; Conflicts of Interest: The authors declare no competing interestsPlease use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.